The robust weight loss combined with a well-tolerated safety profile reinforces our confidence in the clinical development programme as we advance to phase III trials. CT-388 is an important asset for unlocking the promise of our obesity pipeline, according to Roche, who added that the treatment is considered as a combination asset for petrelintide, an amylin analogue
Tirzepatide is a once-weekly injectable medication that demands consistent timing to maintain steady therapeutic levels in your bloodstream
While rare cases of appendicitis have been reported among semaglutide users, clinical trials and post-marketing data do not support a significant association
Thats vitamin B12
Your doctor will evaluate your medical history, current medications, and overall health to determine if this combination is appropriate
GLP-1 Bridge is a workaround, since it operates outside the Part D benefit, runs on CMSs demonstration authority, and expires on December 31, 2027